AdvaMed Unveils National COVID-19 Testing Supply Registry

AdvaMed and 13 diagnostic companies have created a national testing supply registry to assist state and federal governments in their response to the COVID-19 pandemic.

The registry gathers and analyzes information from the diagnostic companies, along with publicly available data on daily tests performed, to create a “centralized, standardized and ‘living’ picture of our COVID-19 diagnostic supply,” according to AdvaMed CEO Scott Whitaker.

The registry will create a better understanding of the supply of COVID tests to help increase testing availability, he said.